The Empty Capsules market size is expected to reach $5.74 billion in 2030 at a CAGR of 10.6%, driven by growing pharmaceutical industry.
Read More
The Emphysema Treatment market size is expected to reach $7.91 billion in 2030 at a CAGR of 8.1%, driven by rising COPD prevalence.
Read More
The Eltrombopag Drugs market size is expected to reach $3.77 billion in 2030 at a CAGR of 8.6%, driven by rising thrombocytopenia prevalence and clinical trials.
Read More
The Electrocompetent Cells market size is expected to reach $2.51 billion in 2030 at a CAGR of 9.8%, driven by rising genetic engineering demand.
Read More
The G-CSF (Granulocyte Colony Stimulating Factors) market size is expected to reach $12.21 billion in 2030 at a CAGR of 5.3%, driven by rising cancer prevalence.
Read More
The Gastroparesis Drugs market size is expected to reach $7.37 billion in 2030 at a CAGR of 5.2%, driven by rising diabetes prevalence.
Read More
The Gastrointestinal Therapeutics market size is expected to reach $55.21 billion in 2030 at a CAGR of 5.4%, driven by rising inflammatory bowel diseases.
Read More
The Gastrointestinal Over-The-Counter (OTC) Drugs market size is expected to reach $73.3 billion in 2030 at a CAGR of 8.1%, driven by rising digestive disorders.
Read More
The Gastroesophageal Reflux Disease Therapeutics market size is expected to reach $8.38 billion in 2030 at a CAGR of 6.9%, driven by adoption of self-medication.
Read More
The Gastric Cancer Therapy market size is expected to reach $6.96 billion in 2030 at a CAGR of 9.1%, driven by rising Helicobacter pylori prevalence.
Read More